Tanya J. Fjelsta v. Zogg Dermatology, Plc

488 F.3d 804, 26 I.E.R. Cas. (BNA) 230, 2007 U.S. App. LEXIS 12346, 89 Empl. Prac. Dec. (CCH) 42,841, 100 Fair Empl. Prac. Cas. (BNA) 1511
CourtCourt of Appeals for the Eighth Circuit
DecidedMay 29, 2007
Docket06-1965
StatusPublished
Cited by29 cases

This text of 488 F.3d 804 (Tanya J. Fjelsta v. Zogg Dermatology, Plc) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tanya J. Fjelsta v. Zogg Dermatology, Plc, 488 F.3d 804, 26 I.E.R. Cas. (BNA) 230, 2007 U.S. App. LEXIS 12346, 89 Empl. Prac. Dec. (CCH) 42,841, 100 Fair Empl. Prac. Cas. (BNA) 1511 (8th Cir. 2007).

Opinion

LOKEN, Chief Judge.

Registered nurse Tanya Fjelsta sued her former employer, Zogg Dermatology, a clinic in Albert Lea, Minnesota, and the clinic’s supervisors, medical director Brian Zogg and office manager Deanne Zogg. Fjelsta asserted retaliation claims under the Minnesota Whistleblower Act, Minn. Stat. § 181.932; pregnancy discrimination claims under Title VII and the Minnesota Human Rights Act; and claims of defamation and battery. Fjelsta appeals the district court’s 1 grant of summary judgment. Fjelsta v. Zogg Dermatology PLC, No. Civ. 04-1717, 2006 WL 475283 (D.Minn. Feb.28, 2006). Reviewing the grant of summary judgment de novo and the evidence in the light most favorable to Fjels-ta, the non-moving party, we affirm.

I. Background

Fjelsta began working at the clinic on January 27, 2003. At the end of a ninety-day probationary period, she received a guardedly positive written review and an offer of permanent employment, which she accepted. In early June, Roxanne Medd, the clinic’s other full-time nurse, advised that she was pregnant. Fjelsta alleges that Deanne Zogg told her, “Tanya, you better take precautions so both you girls don’t end up pregnant. We can’t have both nurses gone at the same time.” On July 10, Fjelsta told Deanne Zogg she was pregnant. On July 23, Deanne Zogg gave Fjelsta an unfavorable written six-month performance review that placed her on ninety-day probation. Among other criticisms, the review noted that Fjelsta had failed to follow proper sterile procedures during a recent surgery.

On August 11, Fjelsta delivered a lengthy written response to the negative six-month review. This letter addressed many criticisms in the review but not Fjelsta’s alleged failure to follow proper sterile procedures during the recent surgery. Instead, the letter’s “final rebuttal” returned to a subject Fjelsta and Deanne Zogg had previously discussed — whether the clinic should change its policy of reusing a syringe with a new sterile needle attached to draw medication from a multi-dose vial and then using that multi-dose vial with other patients. Fjelsta’s letter reiterated her view that this practice was inappropriate “even with excellent technique” and stated:

*808 I cannot and will not accept your policy for the use of multi-dose vials.... I will continue to dispose of these contaminated multi-dose vials, as I cannot knowingly inject a patient with medication contaminated by other patients’ blood products.... The office procedure on [multi-dose vials] as you have instructed me violates Minnesota Rule 6950.1060 Subp. 2A_ I do believe that I am very knowledgeable when it comes to the many aspects of sterile procedures and the improper use of [multi-dose vials] that occurs in this office needs to be rectified now.... I would like to ... discuss further this evaluation and also set up corrective action plan, as you seem [sic] fit.

Deanne Zogg reviewed Fjelsta’s letter and gave it to Dr. Zogg. Less then thirty minutes later, he summoned Fjelsta to his office and asked her to leave for the day. Fjelsta asked why; Deanne Zogg said it was for “insubordination.” When Fjelsta refused to leave, Dr. Zogg escorted her from the clinic, forcibly though not painfully, and locked the outside door. According to affidavits submitted by two clinic employees, Deanne Zogg then called a meeting and informed staff that Fjelsta had been terminated. Later that day or the next, Fjelsta sent Zogg Dermatology an email asking the clinic to confirm that she had been terminated. She also contacted two Peres officials seeking to clarify her status. 2 After checking with Deanne Zogg, they advised Fjelsta she was not terminated. On August 13, Deanne Zogg sent Fjelsta an e-mail advising that she was still an employee and instructing her to report to work the following Tuesday. Fjelsta did not return to work. This lawsuit followed.

II. Discussion

A. Whistleblower Act. Fjelsta first argues that the district court erred in dismissing . her claim under Minn.Stat. § 181.932, subd. 1(a), which provides that an employer may not discharge or punish an employee because the employee “in good faith, reports a violation or suspected violation” of any state law or rule. To recover on this claim, Fjelsta must prove that Zogg Dermatology took adverse employment action against her because she engaged in statutorily protected conduct, here, making a good faith report of a suspected violation of law. See Nichols v. Metro. Ctr. for Indep. Living, Inc., 50 F.3d 514, 516 (8th Cir.1995). There is no question Fjelsta submitted a letter asserting a violation of a specific state rule, Minn. R. 6950.1060, subp. 2A. “The central question is whether the report [was] made for the purpose of blowing the whistle, i.e., to expose an illegality.” Obst v. Microtron, Inc., 614 N.W.2d 196, 202 (Minn.2000).

The district court dismissed this claim on the ground that Fjelsta’s letter was not a report for purposes of § 181.932, subd. 1(a), because “there is no evidence in the record to demonstrate that Fjelsta made the report for the purpose of exposing an illegality.” We agree. Fjelsta testified that, before writing the letter, she discussed her concerns about the clinic’s multi-dose vial policy in a “lengthy conversation” during which Deanne Zogg explained why the clinic’s policy was proper, and Fjelsta questioned that explanation. Thus, Zogg Dermatology was well aware of the alleged violation before Fjelsta wrote the letter. In these circumstances, “it would seem that there was no whistle to blow.” Obst, 614 N.W.2d at 203. The *809 purpose of Fjelsta’s letter was not to expose illegality. Rather, it “merely expressed her dissatisfaction with [the clinic’s] conduct and policy” in an attempt to deflect the performance review’s criticism of her knowledge of sterile procedures. Hitchcock v. FedEx Ground Package Sys., Inc., 442 F.3d 1104, 1106 (8th Cir.2006).

Fjelsta argues that, for summary judgment purposes, the district court was required to accept as true her testimony that she wrote the letter in a good faith effort to expose her employer’s wrongdoing. We disagree. “Whether an employee made a report in ‘good faith’ is a question of fact, but the court may determine as a matter of law that certain conduct does not constitute a report for purposes of the Whistleblower Act.” Cokley v. City of Otsego, 623 N.W.2d 625, 630 (Minn.App.2001). As no reasonable jury could find that Fjelsta wrote the letter for the purpose of exposing a previously unknown illegality, summary judgment was proper.

Fjelsta’s appeal brief also quotes another provision of the Whistleblower Act, § 181.932, subd.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pribyl v. County of Wright
D. Minnesota, 2018
Fassbender v. Correct Care Solutions, LLC
890 F.3d 875 (Tenth Circuit, 2018)
Douglas Sellner v. MAT Holdings, Inc.
859 F.3d 610 (Eighth Circuit, 2017)
Wages v. Stuart Management Corp.
21 F. Supp. 3d 985 (D. Minnesota, 2014)
Pedersen v. Bio-Medical Applications
992 F. Supp. 2d 934 (D. Minnesota, 2014)
Jenna Wood v. SatCom Marketing, LLC
705 F.3d 823 (Eighth Circuit, 2013)
Lenzen v. Workers Compensation Reinsurance Ass'n
705 F.3d 816 (Eighth Circuit, 2013)
Hillins v. Marketing Architects, Inc.
808 F. Supp. 2d 1145 (D. Minnesota, 2011)
Moore v. City of Desloge, Mo.
647 F.3d 841 (Eighth Circuit, 2011)
Elam v. Regions Financial Corp.
601 F.3d 873 (Eighth Circuit, 2010)
Springer v. McLANE COMPANY, INC.
692 F. Supp. 2d 1050 (D. Minnesota, 2010)
Longwell v. Omaha Performing Arts Society
666 F. Supp. 2d 1035 (D. Nebraska, 2009)
Elam v. Regions Financial Corp.
606 F. Supp. 2d 999 (S.D. Iowa, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
488 F.3d 804, 26 I.E.R. Cas. (BNA) 230, 2007 U.S. App. LEXIS 12346, 89 Empl. Prac. Dec. (CCH) 42,841, 100 Fair Empl. Prac. Cas. (BNA) 1511, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tanya-j-fjelsta-v-zogg-dermatology-plc-ca8-2007.